BCL2L1 and cholangiocarcinoma: A significant suppression in BCL-XL expression was observed at the protein level in CCA cell lines following miR-876 overexpression (Fig. 2f, g), without having any effect on expression of BCL-XL at mRNA level (Supplementary Fig. 1).